Covered recipient · General Payments record
LINDA S LUPO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$586.33
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $259.82 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $108.41 | 1 |
| Astellas Pharma US Inc | $36.26 | 2 |
| Acerta Pharma LLC | $21.96 | 1 |
| Lilly USA, LLC | $20.82 | 1 |
| PFIZER INC. | $20.05 | 1 |
| ABBVIE INC. | $19.84 | 1 |
| SHIELD THERAPEUTICS INC | $16.30 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.84 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107566490 | CMS |
| Astellas Pharma US Inc | $17.94 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139493974 | CMS |
| Astellas Pharma US Inc | $18.32 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139531116 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.96 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104504056 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.18 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118133623 | CMS |
| GlaxoSmithKline, LLC. | $108.41 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116699467 | CMS |
| Lilly USA, LLC | $20.82 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135765459 | CMS |
| PFIZER INC. | $20.05 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132117648 | CMS |
| SHIELD THERAPEUTICS INC | $16.30 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150150265 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.